Previous close | 27.75 |
Open | 27.86 |
Bid | 28.68 x 100 |
Ask | 35.62 x 200 |
Day's range | 27.52 - 28.86 |
52-week range | 23.10 - 45.96 |
Volume | |
Avg. volume | 141,645 |
Market cap | 686.034M |
Beta (5Y monthly) | 1.18 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.96 |
Earnings date | 29 Jul 2024 - 02 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 43.00 |
CVRx (CVRX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
WARSAW, Ind., June 04, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS) a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer is scheduled to participate in a fireside chat at the Truist Securities MedTech Conference, being held in Boston, MA. Event:Truist Securities MedTech ConferenceFormat:Fireside ChatDate:Tuesday, June 18, 2024Time:4:45 pm ET An aud
Reinforced Long-Term Commitment as Emerald SponsorWARSAW, Ind., May 15, 2024 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its continued support of the combined 2024 Pediatric Orthopaedic Society of North America (“POSNA”) and European Paediatric Orthopaedic Society (“EPOS”) annual meeting as an Emerald sponsor. At the Annual Meeting, the Company highlighted its growing